00287YDZ9 · USDInvestment Grade · A-

Abbvie Inc 4.88% 2030/03

Abbvie IncSenior Unsecured
MID PRICE
101.78
par = 100
YIELD TO MAT.
4.54%
semi-annual
COUPON
4.875%
semi-annual · fixed
MATURITY
2030-03-15
bullet · 3.86y
OUTSTANDING
not disclosed
AS OF
2026-04-30
Fund disclosure

Sign up free to see prices on this bond

Free accounts get 40 bond price views per month — 4× the anonymous quota. Pro is unlimited.

About this bond

AI BRIEF · GROUNDED IN STRUCTURED DATA
About the issuer

AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. They have produced drugs to treat a wide range of medical issues.

Source: Wikipedia →

Risk analytics

SEMI-ANNUAL · BULLET · PAR 100
Modified duration
3.47 y
1bp ↑ ≈ -0.035% P&L
Convexity
14.40
higher = more curvature
Years to maturity
3.86 y
YTM source
Ingested
Fund disclosure
Market signals · funds disclosing this bond
SignalCategoryExposureLast moveWeightAs of
Invesco BulletShares 2030 Corporate Bond
Invesco
BulletShares 2030 Corporate$6.8M▲ $15K0.27%2026-04-30
Subscribe to reveal which signals are holding this bond.Subscribe →

Price history

Sherpa Signal

AS OF 2026-04-30

Institutional footprint · signal-level holdings

15/ 100Minimal footprint
Interpretation. Minimal institutional footprint, holding
HOLDERS
1
unchanged in 7d
AGGREGATE EXPOSURE
$6.8M
USD across all
TOP CONCENTRATION
100.0%
largest holder
FLOW
unchanged in 7d

Sherpa Signal is derived from a panel of tracked institutional portfolios. Names of individual holders are not disclosed.

100K PAR NOTIONAL · MARKET VALUE
101,777 USD
PRICE
101.78

RFQ routing · coming soon

Security details

AWAITING ENRICHMENT
Face value
100 USD
Seniority
Senior Unsecured

Issuer curve

Abbvie · 10 PTS

Yield (%) plotted against years-to-maturity. This bond highlighted in amber.